Skip to main content
Clinical Trials/ACTRN12623000726651
ACTRN12623000726651
Completed
Phase 2

Assessing renal blood flow, as measured by urinary oxygenation, acute kidney injury (AKI) and biomarkers of AKI (Nephrocheck) in patients undergoing Laparoscopic and Open General Surgery

Austin Health0 sites43 target enrollmentJuly 5, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Surgery requiring general anaesthesia
Sponsor
Austin Health
Enrollment
43
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

il available as currently under peer-review

Registry
who.int
Start Date
July 5, 2023
End Date
March 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult patients aged equal to or greater than 18 years of age.
  • Schedule to have either a laparoscopic or open general surgery
  • Require placement of a urinary catheter as a part of routine clinical care
  • Participant provides own consent

Exclusion Criteria

  • Baseline serum creatinine greater than 200µmol.L\-1 or an estimated glomerular filtration rate according to the CKD\-EPI method below 30ml.min\-1\.1\.73m\-2
  • Patients with acute kidney injury as defined by the KDIGO consensus criteria,
  • pregnant women
  • Pre\-anaesthetics mean arterial pressure greater than 100mmHg or lower than 65mmHg

Outcomes

Primary Outcomes

Not specified

Similar Trials